Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5024,536.63.05%H 24,579.9 · L 24,296.3as of 05 Nov, 3:31 PM IST|Sensex79,310.013.11%H 79,470.03 · L 78,520.56as of 05 Nov, 3:32 PM IST|Bank Nifty57,773.654.02%H 57,847.65 · L 56,718.2as of 05 Nov, 3:31 PM IST|USD / INR₹94.470.17%H ₹94.56 · L ₹94.31as of 05 Nov, 9:10 PM IST|Gold Intl (10g)₹1,24,837.70.92%H ₹1,26,216.55 · L ₹1,23,519.59as of 12:11 AM IST|Silver Intl (1kg)₹1,59,266.470.3%H ₹1,62,470.63 · L ₹1,56,776.03as of 12:11 AM IST|Crude WTI₹8,538.692.58%H ₹8,587.81 · L ₹8,185.39as of 12:11 AM IST|Bitcoin₹71,83,1915.55%H ₹73,82,505.26 · L ₹69,83,876.74as of 12:03 AM IST|Ethereum₹2,12,6137.44%H ₹2,20,527.47 · L ₹2,04,698.53as of 12:03 AM IST|Nifty 5024,536.63.05%H 24,579.9 · L 24,296.3as of 05 Nov, 3:31 PM IST|Sensex79,310.013.11%H 79,470.03 · L 78,520.56as of 05 Nov, 3:32 PM IST|Bank Nifty57,773.654.02%H 57,847.65 · L 56,718.2as of 05 Nov, 3:31 PM IST|USD / INR₹94.470.17%H ₹94.56 · L ₹94.31as of 05 Nov, 9:10 PM IST|Gold Intl (10g)₹1,24,837.70.92%H ₹1,26,216.55 · L ₹1,23,519.59as of 12:11 AM IST|Silver Intl (1kg)₹1,59,266.470.3%H ₹1,62,470.63 · L ₹1,56,776.03as of 12:11 AM IST|Crude WTI₹8,538.692.58%H ₹8,587.81 · L ₹8,185.39as of 12:11 AM IST|Bitcoin₹71,83,1915.55%H ₹73,82,505.26 · L ₹69,83,876.74as of 12:03 AM IST|Ethereum₹2,12,6137.44%H ₹2,20,527.47 · L ₹2,04,698.53as of 12:03 AM IST|
Topicin IPOs

Debt Repayment

Latest news, explainers and analysis on Debt Repayment. Tracking 4 stories on Arth Vani.

4 stories tracked

Connected in the graph

Latest on Debt Repayment

Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion
IPOBreaking
IPOs

Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion

Symbiotec Pharmalab, a global leader in corticosteroid and steroidal-hormone APIs, is planning an Initial Public Offering (IPO) to raise ₹150 crore. The funds are earmarked for repaying existing debt and expanding its operational capabilities. The company has shown consistent revenue and EBITDA growth, primarily driven by its international market presence, particularly in Europe.

73d ago·1 min readListen
Zetwerk Files Updated IPO Papers: Plans to Raise Funds to Repay ₹1,800 Crore Debt
IPOBreaking
IPOs

Zetwerk Files Updated IPO Papers: Plans to Raise Funds to Repay ₹1,800 Crore Debt

Manufacturing unicorn Zetwerk has filed updated draft papers with SEBI for its upcoming Initial Public Offering. The company intends to utilize ₹1,250 crore from the fresh issue to clear its own debt and another ₹550 crore to settle subsidiary borrowings.

83d ago·1 min readListen
Manipal Health Eyes ₹8,000 Cr IPO for Expansion, Debt Repayment
IPOBreaking
IPOs

Manipal Health Eyes ₹8,000 Cr IPO for Expansion, Debt Repayment

Manipal Health Enterprises is planning an ₹8,000 crore Initial Public Offering (IPO) to fund its expansion and repay debt. While the company has shown strong revenue growth, investors are advised to watch for post-listing performance due to aggressive pricing concerns.

98d ago·1 min readListen
PC Jeweller Repays Consortium Bank Debt, Eyes Debt-Free Status by Q2 FY27
Stock Market

PC Jeweller Repays Consortium Bank Debt, Eyes Debt-Free Status by Q2 FY27

PC Jeweller's shares saw a significant jump after the company announced it has cleared outstanding dues to two of its 14 consortium banks. This move is a crucial step in the company's turnaround strategy, with plans to become debt-free by the second quarter of FY27.

120d ago·1 min readListen
IPOs products
Compare & act on the right product for this topic
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
13.6%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.9%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
12.9%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
11.6%
3Y CAGR

IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.

Explore all entities in the Knowledge Graph